UCL Technology Fund and Parkwalk Advisors have backed UCL and Bristol-founded quantum computing software developer Phasecraft.

The fund manager will work with Hungry Jack’s to devise a plant-based version of the latter’s flagship burger, the Whopper, based on Csiro research.

WyoVentures will allow University of Wyoming to manage VC funds while also acting as a conduit to startups from the local ecosystem.

DesertDx has spun out of UA's Tech Launch Arizona to commercialise a comprehensive single blood-draw diagnostics test for lung cancer.

Karolinska Development-backed regenerative implant producer OssDsign has booked $15.8m after selling out the original issue for its forthcoming listing, and is now looking to generate up to $2.4m from the overallotment.

Mercia Technologies has returned to back Warwick-founded medtech spinout Medherant, which is preparing to advance its adhesive Tepi Patch technology through the clinic.

GuideWell Mutual, Blue Shield California and existing backer Premera Blue Cross all invested in the healthcare prediction platform developer based on Stanford research.

The T-Cell therapy developer, based on research at Baylor College of Medicine, has received funding in a Gilead Sciences-backed series B round led by Fidelity Management and Research.

Pixie Dust Technologies, which promotes university-derived technologies from Japan, has received $34.7m in a round that included KDDI, Kansai Electric Power, NEC, Toppan, Dai-ichi Life and Dentsu.

The intermediary close of PSL's deep tech-oriented fund comes after additional contributions from the EIF, Bpifrance and Vilmorin & Cie.